SUMMARY A family is presented in which the mother has transmitted primary hypoparathyroidism with early onset and serum PTH 
Familial idiopathic hypoparathyroidism represents a heterogeneous group of heritable diseases. According to McKusick' autosomal dominant (14620, 14625) The cloned PTH gene fragment p2O-36 revealed two high frequency restriction fragment length polymorphisms using TaqI and PstI.5 Due to a polymorphic TaqI site within the second intron of the prepro-PTH locus, TaqI restriction fragments of either 2 4 or 2 5 kb are generated in addition to a 41 kb invariant fragment. A polymorphic Pstl site 1-7 kb 3' to the coding region produces PstI fragments of either 2 2 or 2 8 kb in addition to another 2 2 kb invariant fragment, and 2 8/2 8 kb homozygotes can be easily distinguished from 2-8/2-2 kb heterozygotes on the basis of relative band intensity.56 Furthermore, an invariant, more faintly cross hybridising 2 3 kb PstI sequence of unknown location and function becomes apparpnt.5
These restriction fragment length polymorphisms were used in order to determine whether the affected mother passed identical or different PTH alleles to her two affected sons. As can be seen in the figure (a), the mother (1.1), the father (1.2), and the older son (11.1) are heterozygous for the 2-5 and 2-4 kb TaqI alleles, while the younger son (11.2) is homozygous for 'the 2-5 kb allele. On the basis of these patterns it is not possible to establish whether the two sons inherited identical or different maternal PTH alleles. The PstI polymorphism in this family can be seen in the figure (b). The mother and son 11.1 are heterozygous for the 2-8 and 2-2 kb PstI alleles, while the 2 2 5-2 - Taq I I   I   I father and son 11.2 are homozygous for the 2 8 kb PstI allele. This interpretation was confirmed by densitometry of the autoradiograph. Thus, the mother has passed the 2-8 kb PTH allele to son 11.2 and the 2-2 kb PTH allele to son 11.1. The disease, therefore, segregates independently of the PTH allelic variants. Paternity was confirmed by HLA typing (data not shown). Discussion We have shown by clinical, immunological, and restriction endonuclease analysis that in a family with idiopathic hypoparathyroidism with low or undetectable serum levels of PTH using 44-68 and C terminal assays, in which the disease seems to be transmitted by the affected mother to both of her sons, the genetic defect is not linked to the PTH gene itself, and that the primary molecular defect must be located elsewhere (for example, defective processing, synthesis, or secretion of PTH). These conclusions are based on the assumption that the pattern of inheritance is in fact autosomal dominant. Several alternatives should, however, be considered. Theoretically, the mother could be homozygous and the father heterozygous for a recessive allele with a 50 % chance of each offspring being affected. However, given the rarity of these disorders in the population, the probability of the father being heterozygous can be considered to be very low. There is no evidence for consanguinity in the parents. Secondly, a crossover event may have occurred during maternal meiosis between the PstI site and the site of a putative mutation in the PTH gene giving rise to the disease. Again, this must be very unlikely. Assuming that 1000 kb of the human genome corresponds to 1 cM, a recombination event would occur with a probability of only 0-002 00. Thirdly, the pedigree could also formally be interpreted as showing X linked dominant inheritance; such a mode of inheritance would also exclude linkage of the disease locus with the PTH gene, because the latter is located on chromosome I .4
While this investigation does not contribute directly to the identification of a genetic defect, it demonstrates the usefulness of recombinant DNA methods in unravelling a heterogeneous group of disorders. It is hoped that this communication will prompt similar analyses of other families with a view to determining the molecular basis of this rare condition. 
